Previous studies have shown associations between zonulin and severity of fatty liver disease in overweight subjects [25,28,54], as well as in patients with magnetic resonance and biopsy-characterized NAFLD and NASH [55]. This evidence concerns the gene HP and metabolic dysfunction-associated steatotic liver disease.